基质-M佐剂：通过为抗原“搭建舞台”增强免疫反应。 - Suppr

Suppr

超能文献

Matrix-M adjuvant: enhancing immune responses by 'setting the stage' for the antigen.

作者信息

Bengtsson Karin Lövgren, Karlsson Karin H, Magnusson Sofia E, Reimer Jenny M, Stertman Linda

出版信息

Expert Rev Vaccines. 2013 Aug;12(8):821-3. doi: 10.1586/14760584.2013.814822.

DOI:10.1586/14760584.2013.814822

PMID:23984954

Abstract

摘要

相似文献

Matrix-M adjuvant: enhancing immune responses by 'setting the stage' for the antigen.

Expert Rev Vaccines. 2013 Aug;12(8):821-3. doi: 10.1586/14760584.2013.814822.

ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza.

Hum Vaccin Immunother. 2015;11(2):377-85. doi: 10.4161/21645515.2014.990859.

Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant.

Immunol Cell Biol. 2009 Jul;87(5):371-6. doi: 10.1038/icb.2009.21. Epub 2009 Apr 21.

ISCOMATRIX adjuvant for antigen delivery.

Adv Drug Deliv Rev. 2005 Jan 10;57(3):465-74. doi: 10.1016/j.addr.2004.09.006.

Adjuvant activities of saponins from traditional Chinese medicinal herbs.

Vaccine. 2009 Aug 6;27(36):4883-90. doi: 10.1016/j.vaccine.2009.06.033. Epub 2009 Jun 24.

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis.

Int J Oncol. 2011 Jul;39(1):287-94. doi: 10.3892/ijo.2011.1032. Epub 2011 May 6.

ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines.

Expert Rev Vaccines. 2007 Oct;6(5):761-72. doi: 10.1586/14760584.6.5.761.

ISCOMs and ISCOMATRIX.

Vaccine. 2009 Jul 16;27(33):4388-401. doi: 10.1016/j.vaccine.2009.05.032. Epub 2009 May 28.

Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori.

Vaccine. 2008 Jul 23;26(31):3880-4. doi: 10.1016/j.vaccine.2008.05.004. Epub 2008 May 23.

Early inflammatory response to the saponin adjuvant Matrix-M in the pig.

Vet Immunol Immunopathol. 2014 Mar 15;158(1-2):53-61. doi: 10.1016/j.vetimm.2013.07.007. Epub 2013 Aug 5.

引用本文的文献

Biodistribution of the saponin-based adjuvant Matrix-M™ following intramuscular injection in mice.

Front Drug Deliv. 2023 Nov 6;3:1279710. doi: 10.3389/fddev.2023.1279710. eCollection 2023.

Evaluation of the transmission-blocking potential of antigen Pvg37 using transgenic rodent parasites and clinical isolates.

Front Cell Infect Microbiol. 2025 Jan 24;15:1529770. doi: 10.3389/fcimb.2025.1529770. eCollection 2025.

Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2.

NPJ Vaccines. 2024 Jan 20;9(1):17. doi: 10.1038/s41541-024-00806-2.

The Matrix-M™ adjuvant: A critical component of vaccines for the 21 century.

Hum Vaccin Immunother. 2023 Dec 31;19(1):2189885. doi: 10.1080/21645515.2023.2189885. Epub 2023 Apr 27.

Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress.

Int J Mol Sci. 2023 Jan 15;24(2):1701. doi: 10.3390/ijms24021701.

Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.

Front Bioeng Biotechnol. 2022 Nov 25;10:1052436. doi: 10.3389/fbioe.2022.1052436. eCollection 2022.

COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy.

Pharmaceuticals (Basel). 2022 Mar 8;15(3):322. doi: 10.3390/ph15030322.

Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.

NPJ Vaccines. 2021 Oct 12;6(1):120. doi: 10.1038/s41541-021-00383-8.

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.

Sci Rep. 2021 May 24;11(1):10792. doi: 10.1038/s41598-021-90290-8.

Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population.

Int Rev Immunol. 2022;41(4):448-463. doi: 10.1080/08830185.2021.1925267. Epub 2021 May 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验